# Colchicine Counteracting Inflammation in COVID-19 Pneumonia

> **NCT04322565** · PHASE2 · COMPLETED · sponsor: **Azienda Ospedaliero-Universitaria di Parma** · enrollment: 193 (actual)

## Conditions studied

- Coronavirus Infections
- Pneumonia, Viral

## Interventions

- **DRUG:** Colchicine

## Key facts

- **NCT ID:** NCT04322565
- **Lead sponsor:** Azienda Ospedaliero-Universitaria di Parma
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-04-20
- **Primary completion:** 2021-09-01
- **Final completion:** 2021-10-01
- **Target enrollment:** 193 (ACTUAL)
- **Last updated:** 2022-07-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04322565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04322565, "Colchicine Counteracting Inflammation in COVID-19 Pneumonia". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04322565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*